Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol versus febuxostat in hyperuricemia with chronic kidney disease
PACTR202607678798356Completed
- Sponsor
- Mohamed Eldougdoug
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of allopurinol and febuxostat in hyperuricemia and chronic kidney disease (CKD) (3 arms), sponsored by Mohamed Eldougdoug. Started May 2024; status: completed.
02
Drugs
allopurinolfebuxostat
03
Conditions
hyperuricemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on PACTR202607678798356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607678798356.